INKON Life Technology Co Ltd Asset Resilience Ratio

Latest as of March 2026: 5.73%

INKON Life Technology Co Ltd asset resilience ratio. INKON Life Technology Co Ltd (300143) has an Asset Resilience Ratio of 5.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can INKON Life Technology Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥239.00 Million
≈ $34.97 Million USD Cash + Short-term Investments

Total Assets

CN¥4.17 Billion
≈ $610.67 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of INKON Life Technology Co Ltd (2016–2025)

Asset resilience ratio of INKON Life Technology Co Ltd from 2016 to 2025. This chart shows how INKON Life Technology Co Ltd's Asset Resilience Ratio has changed over time. Read 300143 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down INKON Life Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see INKON Life Technology Co Ltd (300143) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥239.00 Million 5.73%
Total Liquid Assets CN¥239.00 Million 5.73%

Asset Resilience Insights

  • Limited Liquidity: INKON Life Technology Co Ltd maintains only 5.73% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

INKON Life Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare INKON Life Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

INKON Life Technology Co Ltd Asset Resilience Ratio by Year (2016–2025)

INKON Life Technology Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for INKON Life Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 4.75% CN¥199.00 Million
≈ $29.12 Million
CN¥4.19 Billion
≈ $613.51 Million
+3.90pp
2024-12-31 0.85% CN¥30.00 Million
≈ $4.39 Million
CN¥3.54 Billion
≈ $517.54 Million
-10.47pp
2020-12-31 11.32% CN¥300.14 Million
≈ $43.92 Million
CN¥2.65 Billion
≈ $387.89 Million
+10.96pp
2018-12-31 0.36% CN¥9.43 Million
≈ $1.38 Million
CN¥2.62 Billion
≈ $383.74 Million
+0.12pp
2017-12-31 0.24% CN¥6.22 Million
≈ $909.92K
CN¥2.61 Billion
≈ $382.08 Million
-19.49pp
2016-12-31 19.73% CN¥500.00 Million
≈ $73.17 Million
CN¥2.53 Billion
≈ $370.79 Million
--
pp = percentage points

About INKON Life Technology Co Ltd

SHE:300143 China Medical Devices
Market Cap
$821.42 Million
CN¥5.61 Billion CNY
Market Cap Rank
#9474 Global
#2342 in China
Share Price
CN¥7.49
Change (1 day)
+1.35%
52-Week Range
CN¥6.57 - CN¥13.38
All Time High
CN¥29.11
About

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was … Read more